...
机译:ANLN的过度表达有助于乳腺癌患者中蒽环类化疗的预后不良
Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;
Hunan Prov Clin Meditech Res Ctr Breast Canc Changsha 410008 Hunan Peoples R China;
Hunan Prov Clin Meditech Res Ctr Breast Canc Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Pathol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp 3 Dept Pathol Changsha 410013 Hunan Peoples R China;
Cent S Univ Xiangya Hosp 3 Dept Pain Changsha 410013 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Clin Pharmacol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;
Cent S Univ Xiangya Hosp Dept Oncol Changsha 410008 Hunan Peoples R China;
ANLN; Breast cancer; Anthracycline; Prognosis;
机译:ANLN的过度表达导致乳腺癌患者中蒽环类化疗的预后不良
机译:Foxc1过表达是对散核三核苷酸乳腺癌的蒽环类佐剂化疗不良的标志物
机译:FoxC1过表达是对散核三级阴性乳腺癌的基于蒽环类佐剂化疗的反应不佳的标志
机译:HER-2和p53在乳腺癌紫杉烷类和蒽环类新辅助化疗中的临床意义
机译:辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
机译:FOXC1过表达是散发性三阴性乳腺癌对基于蒽环类辅助化疗的不良反应的标志
机译:BRCaness作为预测三阴性乳腺癌患者蒽环类辅助化疗预后和反应的生物标志物。
机译:乳腺内卷入引起的外泌体可以作为乳腺癌预后不良和预防的标志物。